Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data

DH Kim, CM Park, D Ko, KJ Lin, RJ Glynn - Drugs & Aging, 2024 - Springer
The objective of this review is to summarize and appraise the research methodology,
emerging findings, and future directions in pharmacoepidemiologic studies assessing the …

Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes

PT Htoo, M NajafZadeh, H Tesfaye… - Diabetes …, 2024 - diabetesjournals.org
OBJECTIVE We compared health care resource utilization (HCRU) and costs for inpatient
and outpatient services and dispensed medications in older adults with type 2 diabetes …

[PDF][PDF] Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes

BH vor der HĻohe, PT Htoo - researchgate.net
Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2
Diabetes Page 1 Health Care Utilization and Costs Associated With Empagliflozin in Older …